-
What’s hot and what’s not among MS therapies?
The new kids on the MS block, disease-modifying therapies (DMT) such as Genentech’s Ocrevus (ocrelizumab) and Sanofi Genzyme’s Lemtrada (alemtuzumab), are attracting a lot of interest these days. But, some DMTs that have been around for more than two decades are still being prescribed by a lot of neurologists.
Read more about “What’s Hot and What’s Not Among MS Therapies?”.
What do you know about these therapies? Which ones have you already tried? Did they work?
-
0 Replies
Sorry, there were no replies found.
Log in to reply.